CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Press and News Items

Welcome to our news section. This is where we provide you with first hand news and information from and about CHEPLAPHARM. We offer you a broad range of current information and materials for all publishing needs. All texts and images are free to use for editorial purposes.

News-Categories

All News

Investors Domain Investor Relations Press releases

11/19/2021

CHEPLAPHARM continues strong Growth

more chevron_right
Investors Domain Investor Relations Press releases

10/13/2021

CHEPLAPHARM signed deal

more chevron_right
Investor Relations Press releases

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives

more chevron_right
Investor Relations Press releases

05/04/2021

CHEPLAPHARM continues on the road to success

more chevron_right
Investor Relations Press releases

04/01/2021

Changes of Management Board per April

more chevron_right
Investor Relations Press releases

03/01/2021

Changes of CHEPLAPHARM Management Board per March

more chevron_right
Investor Relations Press releases

02/03/2021

CHEPLAPHARM Arzneimittel GmbH Announces Receipt of Required Consents

more chevron_right
Investor Relations Press releases

01/26/2021

CHEPLAPHARM Arzneimittel GmbH Announces Consent Solicitation

more chevron_right
Investors Domain Investor Relations Press releases

01/11/2021

CHEPLAPHARM acquires rights to Rivotril®

more chevron_right
Back to top expand_less